ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

In Brief: Ozer, Comis Join Allegheny Cancer Centers; Two Cooperative Groups Under Same Roof

March 21, 1997

ACS Adopts Principles As Basis For Reform Of Health Care System

July 17, 1992